43 related articles for article (PubMed ID: 38717723)
1. Comparing characteristics of individuals screened for lung cancer with 2021 versus 2013 USPSTF recommendations.
Henderson LM; Durham DD; Gruden J; Pritchard M; Lane L; Long J; Bellinger C; Rivera MP
J Natl Cancer Inst; 2024 Jun; ():. PubMed ID: 38913873
[TBL] [Abstract][Full Text] [Related]
2. Lung Cancer Screening in the US, 2022.
Bandi P; Star J; Ashad-Bishop K; Kratzer T; Smith R; Jemal A
JAMA Intern Med; 2024 Jun; ():. PubMed ID: 38856988
[TBL] [Abstract][Full Text] [Related]
3. Plain language summary and patient perspective of the 2020 lung cancer screening recommendations by the US Preventive Services Task Force.
Jenkins R; Walker J; Roy UB; Feldman J
Future Oncol; 2024 Jun; ():1-7. PubMed ID: 36935636
[TBL] [Abstract][Full Text] [Related]
4. Patient counseling for breast cancer screening: Taking changes to USPSTF recommendations into account.
Pleasant V
OBG Manag; 2023 Dec; 35(12):43-49. PubMed ID: 38835939
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the characteristics of the population eligible for lung cancer screening under 2013 and population newly eligible under 2021 US Preventive Services Task Force recommendations.
Yell N; Eberth JM; Alberg AJ; Hung P; Schootman M; McLain AC; Munden RF
Cancer Causes Control; 2024 May; ():. PubMed ID: 38717723
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Population-Level Changes Associated With the 2021 US Preventive Services Task Force Lung Cancer Screening Recommendations in Community-Based Health Care Systems.
Ritzwoller DP; Meza R; Carroll NM; Blum-Barnett E; Burnett-Hartman AN; Greenlee RT; Honda SA; Neslund-Dudas C; Rendle KA; Vachani A
JAMA Netw Open; 2021 Oct; 4(10):e2128176. PubMed ID: 34636916
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data.
Williams RM; Li T; Luta G; Wang MQ; Adams-Campbell L; Meza R; Tammemägi MC; Taylor KL
Cancer; 2022 May; 128(9):1812-1819. PubMed ID: 35201610
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Revised US Preventive Services Task Force Lung Cancer Screening Guideline Among Women and Racial/Ethnic Minority Populations.
Reese TJ; Schlechter CR; Potter LN; Kawamoto K; Del Fiol G; Lam CY; Wetter DW
JAMA Netw Open; 2021 Jan; 4(1):e2033769. PubMed ID: 33433600
[TBL] [Abstract][Full Text] [Related]
9. Racial and Ethnic Disparities in Lung Cancer Screening Eligibility.
Narayan AK; Chowdhry DN; Fintelmann FJ; Little BP; Shepard JO; Flores EJ
Radiology; 2021 Dec; 301(3):712-720. PubMed ID: 34546133
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Lung Cancer Screening in the US, 2022.
Henderson LM; Su IH; Rivera MP; Pak J; Chen X; Reuland DS; Lund JL
JAMA Netw Open; 2024 Mar; 7(3):e243190. PubMed ID: 38512257
[TBL] [Abstract][Full Text] [Related]
11. Screening for lung cancer: 2023 guideline update from the American Cancer Society.
Wolf AMD; Oeffinger KC; Shih TY; Walter LC; Church TR; Fontham ETH; Elkin EB; Etzioni RD; Guerra CE; Perkins RB; Kondo KK; Kratzer TB; Manassaram-Baptiste D; Dahut WL; Smith RA
CA Cancer J Clin; 2024; 74(1):50-81. PubMed ID: 37909877
[TBL] [Abstract][Full Text] [Related]
12. Lung cancer diagnosis and mortality beyond 15 years since quit in individuals with a 20+ pack-year history: A systematic review.
Kondo KK; Rahman B; Ayers CK; Relevo R; Griffin JC; Halpern MT
CA Cancer J Clin; 2024; 74(1):84-114. PubMed ID: 37909870
[TBL] [Abstract][Full Text] [Related]
13. Persistent race- and sex-based disparities in lung cancer screening eligibility.
Potter AL; Senthil P; Srinivasan D; Raman V; Kumar A; Haridas C; Mathey-Andrews C; Zheng W; Jeffrey Yang CF
J Thorac Cardiovasc Surg; 2024 Jul; 168(1):248-260.e2. PubMed ID: 37863179
[TBL] [Abstract][Full Text] [Related]
14. Breast, Prostate, Colorectal, and Lung Cancer Incidence and Risk Factors in Women Who Have Sex with Women and Men Who Have Sex with Men: A Cross-Sectional and Longitudinal Analysis Using UK Biobank.
Underwood S; Lyratzopoulos G; Saunders CL
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046692
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms Contributing to the Comorbidity of COPD and Lung Cancer.
Forder A; Zhuang R; Souza VGP; Brockley LJ; Pewarchuk ME; Telkar N; Stewart GL; Benard K; Marshall EA; Reis PP; Lam WL
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769181
[TBL] [Abstract][Full Text] [Related]
16. Potential Impact of Criteria Modifications on Race and Sex Disparities in Eligibility for Lung Cancer Screening.
Smeltzer MP; Liao W; Faris NR; Fehnel C; Goss J; Shepherd CJ; Ramos R; Qureshi T; Mukhopadhyay A; Ray MA; Osarogiagbon RU
J Thorac Oncol; 2023 Feb; 18(2):158-168. PubMed ID: 36208717
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular disease and risk of lung cancer incidence and mortality: A nationwide matched cohort study.
Wang C; Lu D; Cronin-Fenton D; Huang C; Liew Z; Wei D; Qin G; Yu Y; Li J
Front Oncol; 2022; 12():950971. PubMed ID: 36147909
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
